Observational Study Gemigliptin in Patients Aged ≥ 65 Years With Type 2 Diabetes Mellitus

Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study)

NCT03202563 ·Status: COMPLETED ·Phase: PHASE4

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone.

NCT02056600 ·Status: COMPLETED ·Phase: PHASE1

Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)

NCT01890629 ·Status: COMPLETED ·Phase: PHASE4

BE Study of the Combinations of Gemigliptin/Metformin HCl Extended Release 50/1000mg(25/500mg x 2 Tablets) in Comparison to Each Component Administered Alone

NCT03355014 ·Status: COMPLETED ·Phase: PHASE1

Study of the Durability of Glycemic Control With Nateglinide

NCT00858013 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin

NCT01990469 ·Status: COMPLETED ·Phase: PHASE3

Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia

NCT02186080 ·Status: COMPLETED ·Phase: NA

Effect of Gemigliptin Versus Glimepiride on Cardiac Diastolic Function in Patients With Type 2 Diabetes

NCT05663736 ·Status: UNKNOWN ·Phase: PHASE4

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone

NCT01662674 ·Status: COMPLETED ·Phase: PHASE1

A Study to Compare the Safety and Drug Levels in Blood When Using Various Forms of GSK189075 Given to Healthy Subjects

NCT00559884 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.

NCT00762957 ·Status: TERMINATED ·Phase: PHASE3

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered Alone

NCT02670018 ·Status: UNKNOWN ·Phase: PHASE1

Initial Combination of Gemigliptin and Metformin on Microbiota Change

NCT02609815 ·Status: COMPLETED ·Phase: NA

A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263

NCT01128621 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male Subjects

NCT01768455 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin Alone

NCT04255238 ·Status: UNKNOWN ·Phase: PHASE3

A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal

NCT07333742 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01 Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg, and to Evaluate the Effect of Food on the Pharmacokinetics of DA-1229_01 in Healthy Male Volunteers

NCT02167061 ·Status: COMPLETED ·Phase: PHASE1

A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects

NCT02088918 ·Status: COMPLETED ·Phase: PHASE1

Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers

NCT01725672 ·Status: TERMINATED ·Phase: PHASE1

Study Comparing Efficacy and Safety of Amaryl M and Metformin Uptitraion to Type 2 DM

NCT00612144 ·Status: COMPLETED ·Phase: PHASE4

CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)

NCT03317028 ·Status: COMPLETED ·Phase: PHASE2

Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus

NCT01037842 ·Status: COMPLETED ·Phase: PHASE3

An Assessment of Pharmacokinetic Gemigliptin and Metformin Interactions in Healthy Mexican Volunteers

NCT03310749 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers(Fed)

NCT03927170 ·Status: COMPLETED ·Phase: PHASE1